NDASEC stock news
This page provides real-time market news, earnings updates, and company announcements related to NDA Securities Ltd. (NDASEC).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-02-19 18:47 IST
The most ridiculous moments in technology this year
101 finance2025-12-31 14:03:09
BridgeBio Reports Positive Phase 3 Topline Results for Oral Infigratinib with the First Statistically Significant Improvements in Body Proportionality in Achondroplasia
Finviz2026-02-12 12:36:09
BridgeBio Nears 52-Week High On Strong Dwarfism Trial Data, Plans FDA Filing In 2026
Finviz2026-02-12 17:48:41
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof
Finviz2026-02-13 11:21:20
Iterum Therapeutics Provides Business Update
Finviz2026-02-13 13:03:43
Nasus Pharma Announces Closing of $15.0 Million Private Placement
Finviz2026-02-13 13:03:45
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800
Finviz2026-02-13 14:54:40
Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?
Finviz2026-02-13 15:01:04
Why Is Immunic Stock Soaring Friday?
Finviz2026-02-13 18:57:12
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Finviz2026-02-13 20:09:38
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)
Finviz2026-02-16 17:24:48
Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44
Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Finviz2026-02-17 12:03:44
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy
Finviz2026-02-17 14:15:47
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-18 12:03:22
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Finviz2026-02-18 12:03:22
FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma
Finviz2026-02-18 17:39:39
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
Finviz2026-02-19 11:03:48
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Iterum Therapeutics Provides Business Update
Finviz2026-02-13 13:03:43
Nasus Pharma Announces Closing of $15.0 Million Private Placement
Finviz2026-02-13 13:03:45
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800
Finviz2026-02-13 14:54:40
Where is Regeneron Pharmaceuticals (REGN) Headed According to Analysts?
Finviz2026-02-13 15:01:04
Why Is Immunic Stock Soaring Friday?
Finviz2026-02-13 18:57:12
Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
Finviz2026-02-13 20:09:38
FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)
Finviz2026-02-16 17:24:48
Ocular Therapeutix Reports Positive Results from Landmark SOL-1 Phase 3 Superiority Trial in Wet AMD
Finviz2026-02-17 12:03:44
Axsome Therapeutics Settles SUNOSI (solriamfetol) Patent Litigation with Alkem Laboratories Ltd.
Finviz2026-02-17 12:03:44
Cingulate Announces the Closing of a $12 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Finviz2026-02-17 13:06:06
COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy
Finviz2026-02-17 14:15:47
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes
Finviz2026-02-17 14:18:04
Axsome Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Finviz2026-02-18 12:03:22
Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer
Finviz2026-02-18 12:03:22
FDA Accepts BMY's NDA for Iberdomide Combo in Multiple Myeloma
Finviz2026-02-18 17:39:39
Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease
Finviz2026-02-19 11:03:48
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
NDASEC stock price change
On the last trading day, NDASEC stock closed at 30.27 INR, with a price change of 3.49% for the day.
Trade stock futuresNDASEC stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more